相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商:
齐源
- 库存:
999
- 靶点:
TIGIT (Vstm3)
- 级别:
TIGIT (Vstm3) Antibody
- 目录编号:
TIGIT (Vstm3) Antibody
- 克隆性:
单克隆
- 抗原来源:
小鼠
- 保质期:
TIGIT (Vstm3) Antibody
- 抗体英文名:
Cyanine7 anti-mouse TIGIT (Vstm3) Antibody-PE
- 抗体名:
TIGIT (Vstm3) Antibody
- 标记物:
PE
- 宿主:
小鼠
- 适应物种:
小鼠
- 免疫原:
TIGIT (Vstm3) Antibody
- 亚型:
TIGIT (Vstm3) Antibody
- 形态:
TIGIT (Vstm3) Antibody
- 应用范围:
FC
- 保存条件:
2-8℃
- 浓度:
TIGIT (Vstm3) Antibody
- 规格:
25 ug/100 ug
| 规格: | 25 ug | 产品价格: | ¥2500.0 |
|---|---|---|---|
| 规格: | 100 ug | 产品价格: | ¥6500.0 |
Cyanine7 anti-mouse TIGIT (Vstm3) Antibody-PE详细如下:
Description :T cell immunoreceptor with Ig and ITIM domains (TIGIT), also known as V-set andtransmembrane domain-containing protein 3 (Vstm3), is a 26 kD, type I transmembrane proteinand member of the CD28 family. TIGIT is expressed on activated T cells, follicular T helper,memory, and regulatory T cells as well as on NK cells. Its binding partners include CD155(PVR) and CD112 (PVRL2). TIGIT is a negative regulator of NK and T cell activation.Engagement of TIGIT by dendritic cells results in their differentiation into a tolerogenicphenotype, with an increased secretion of IL-10 and a diminished production of IL-12. Micedeficient for TIGIT are more susceptible to autoimmune disease.
Verified Reactivity :Mouse
Antibody Type :Monoclonal
Host Species :Mouse
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application :FC - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cellsin 100 µl volume. It is recommended that the reagent be titrated for optimal performance for eachapplication.
Excitation Laser :Blue Laser (488 nm)、Green Laser (532 nm)、Yellow-Green Laser (561 nm)
Description :T cell immunoreceptor with Ig and ITIM domains (TIGIT), also known as V-set andtransmembrane domain-containing protein 3 (Vstm3), is a 26 kD, type I transmembrane proteinand member of the CD28 family. TIGIT is expressed on activated T cells, follicular T helper,memory, and regulatory T cells as well as on NK cells. Its binding partners include CD155(PVR) and CD112 (PVRL2). TIGIT is a negative regulator of NK and T cell activation.Engagement of TIGIT by dendritic cells results in their differentiation into a tolerogenicphenotype, with an increased secretion of IL-10 and a diminished production of IL-12. Micedeficient for TIGIT are more susceptible to autoimmune disease.
Verified Reactivity :Mouse
Antibody Type :Monoclonal
Host Species :Mouse
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application :FC - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cellsin 100 µl volume. It is recommended that the reagent be titrated for optimal performance for eachapplication.
Excitation Laser :Blue Laser (488 nm)、Green Laser (532 nm)、Yellow-Green Laser (561 nm)
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Application References(PubMed link indicatesBioLegend citation):
1. Joller N, et al. 2010. J. Immunol. 186:1338.
Product Citations:
1. Bertrand F, et al. 2017. Nat Commun. 8:2256. PubMed
2. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
3. Weulersse M, et al. 2020. Immunity. 53(4):824-839.e10. PubMed
4. Zhao H, et al. 2021. Int J Nanomedicine. 16:4913. PubMed
5. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
6. Xiao S, et al. 2020. Cell Reports. 32(2):107892. PubMed
7. Tian M, et al. 2021. Elife. 10:. PubMed
8. Zhao H, et al. 2022. Int J Biol Sci. 18:154. PubMed
9. Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
10. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
1. Joller N, et al. 2010. J. Immunol. 186:1338.
Product Citations:
1. Bertrand F, et al. 2017. Nat Commun. 8:2256. PubMed
2. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
3. Weulersse M, et al. 2020. Immunity. 53(4):824-839.e10. PubMed
4. Zhao H, et al. 2021. Int J Nanomedicine. 16:4913. PubMed
5. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
6. Xiao S, et al. 2020. Cell Reports. 32(2):107892. PubMed
7. Tian M, et al. 2021. Elife. 10:. PubMed
8. Zhao H, et al. 2022. Int J Biol Sci. 18:154. PubMed
9. Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
10. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
文献支持
Cyanine7 抗小鼠 TIGIT (Vstm3) 荧光标记PE 抗体
¥2500 - 6500










